1. Thinakaran G, Koo EH: Amyloid precursor protein trafficking, processing, and function. The Journal of biological chemistry 2008, 283(44):29615-29619.
2. Brown MS, Ye J, Rawson RB, Goldstein JL: Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 2000, 100(4):391-398.
3. Kenchappa RS, Zampieri N, Chao MV, Barker PA, Teng HK, Hempstead BL, Carter BD: Ligand-dependent cleavage of the P75 neurotrophin receptor is necessary for NRIF nuclear translocation and apoptosis in sympathetic neurons. Neuron 2006, 50(2):219-232.
4. Yao XQ, Jiao SS, Saadipour K, Zeng F, Wang QH, Zhu C, Shen LL, Zeng GH, Liang CR, Wang J et al: p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease. Molecular psychiatry 2015, 20(11):1301-1310.
5. Wunderlich P, Glebov K, Kemmerling N, Tien NT, Neumann H, Walter J: Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and γ-secretase-dependent intramembranous cleavage. The Journal of biological chemistry 2013, 288(46):33027-33036.
6. Zhong L, Xu Y, Zhuo R, Wang T, Wang K, Huang R, Wang D, Gao Y, Zhu Y, Sheng X et al: Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model. Nature communications 2019, 10(1):1365.
7. Ewers M, Franzmeier N, Suárez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, Piccio L, Cruchaga C, Deming Y, Dichgans M et al: Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease. Science translational medicine 2019, 11(507).
8. Petruccelli E, Feyder M, Ledru N, Jaques Y, Anderson E, Kaun KR: Alcohol Activates Scabrous-Notch to Influence Associated Memories. Neuron 2018, 100(5):1209-1223 e1204.
9. Morrison SJ, Perez SE, Qiao Z, Verdi JM, Hicks C, Weinmaster G, Anderson DJ: Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell 2000, 101(5):499-510.
10. Yeo SY, Chitnis AB: Jagged-mediated Notch signaling maintains proliferating neural progenitors and regulates cell diversity in the ventral spinal cord. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(14):5913-5918.
11. Javier-Torrent M, Marco S, Rocandio D, Pons-Vizcarra M, Janes PW, Lackmann M, Egea J, Saura CA: Presenilin/gamma-secretase-dependent EphA3 processing mediates axon elongation through non-muscle myosin IIA. Elife 2019, 8.
12. Joanna Bernaciak BW-K, Jennifer Castañeda, Anna Kutkowska-Kaźmierczak, Beata Nowakowska: A novel de novo 20q13.11q13.12 microdeletion in a boy with neurodevelopmental disorders - case report. Dev Period Med 2017, 21(2):91-94.
13. Lim SH, Shin S, Kim MH, Kim EC, Lee DY, Moon J, Park HY, Ryu YK, Kang YM, Kang YJ et al: Depression-like behaviors induced by defective PTPRT activity through dysregulated synaptic functions and neurogenesis. Journal of cell science 2020.
14. Schuurs-Hoeijmakers JH, Vulto-van Silfhout AT, Vissers LE, van de V, II, van Bon BW, de Ligt J, Gilissen C, Hehir-Kwa JY, Neveling K, del Rosario M et al: Identification of pathogenic gene variants in small families with intellectually disabled siblings by exome sequencing. Journal of medical genetics 2013, 50(12):802-811.
15. Thirtamara Rajamani K, O'Neill B, Han DD, Frostholm A, Rotter A, Gu HH: Inactivation of the catalytic phosphatase domain of PTPRT/RPTPρ increases social interaction in mice. Autism research : official journal of the International Society for Autism Research 2015, 8(1):19-28.
16. Lim SH, Kwon SK, Lee MK, Moon J, Jeong DG, Park E, Kim SJ, Park BC, Lee SC, Ryu SE et al: Synapse formation regulated by protein tyrosine phosphatase receptor T through interaction with cell adhesion molecules and Fyn. EMBO J 2009, 28(22):3564-3578.
17. Park AR, Oh D, Lim SH, Choi J, Moon J, Yu DY, Park SG, Heisterkamp N, Kim E, Myung PK et al: Regulation of dendritic arborization by BCR Rac1 GTPase-activating protein, a substrate of PTPRT. Journal of cell science 2012, 125(Pt 19):4518-4531.
18. Zhang X, Guo A, Yu J, Possemato A, Chen Y, Zheng W, Polakiewicz RD, Kinzler KW, Vogelstein B, Velculescu VE et al: Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(10):4060-4064.
19. Peterson WM, Wang Q, Tzekova R, Wiegand SJ: Ciliary neurotrophic factor and stress stimuli activate the Jak-STAT pathway in retinal neurons and glia. The Journal of neuroscience : the official journal of the Society for Neuroscience 2000, 20(11):4081-4090.
20. Nicolas CS, Amici M, Bortolotto ZA, Doherty A, Csaba Z, Fafouri A, Dournaud P, Gressens P, Collingridge GL, Peineau S: The role of JAK-STAT signaling within the CNS. Jak-stat 2013, 2(1):e22925.
21. Lui VW, Peyser ND, Ng PK, Hritz J, Zeng Y, Lu Y, Li H, Wang L, Gilbert BR, General IJ et al: Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer. Proceedings of the National Academy of Sciences of the United States of America 2014, 111(3):1114-1119.
22. Peyser ND, Freilino M, Wang L, Zeng Y, Li H, Johnson DE, Grandis JR: Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer. Oncogene 2016, 35(9):1163-1169.
23. Hong S, Song MR: Signal transducer and activator of transcription-3 maintains the stemness of radial glia at mid-neurogenesis. The Journal of neuroscience : the official journal of the Society for Neuroscience 2015, 35(3):1011-1023.
24. Lee S, Shen R, Cho HH, Kwon RJ, Seo SY, Lee JW, Lee SK: STAT3 promotes motor neuron differentiation by collaborating with motor neuron-specific LIM complex. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(28):11445-11450.
25. Sehara Y, Sawicka K, Hwang JY, Latuszek-Barrantes A, Etgen AM, Zukin RS: Survivin Is a transcriptional target of STAT3 critical to estradiol neuroprotection in global ischemia. The Journal of neuroscience : the official journal of the Society for Neuroscience 2013, 33(30):12364-12374.
26. Wan J, Fu AK, Ip FC, Ng HK, Hugon J, Page G, Wang JH, Lai KO, Wu Z, Ip NY: Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience 2010, 30(20):6873-6881.
27. McGregor G, Irving AJ, Harvey J: Canonical JAK-STAT signaling is pivotal for long-term depression at adult hippocampal temporoammonic-CA1 synapses. FASEB J 2017, 31(8):3449-3466.
28. Zhang Y, Zhang Z, Li L, Xu K, Ma Z, Chow HM, Herrup K, Li J: Selective loss of 5hmC promotes neurodegeneration in the mouse model of Alzheimer's disease. FASEB J 2020, 34(12):16364-16382.
29. Xu M, Zhang DF, Luo R, Wu Y, Zhou H, Kong LL, Bi R, Yao YG: A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association 2018, 14(2):215-229.
30. Matarin M, Salih DA, Yasvoina M, Cummings DM, Guelfi S, Liu W, Nahaboo Solim MA, Moens TG, Paublete RM, Ali SS et al: A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep 2015, 10(4):633-644.
31. Eric M Blalock JWG, Kuey Chu Chen, Nada M Porter, William R Markesbery, Philip W Landfield: Incipient Alzheimer’s disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses.pdf>. Proceedings of the National Academy of Sciences of the United States of America 2004 Feb 17, 101(7):2173-2178.
32. Li J, Han YR, Plummer MR, Herrup K: Cytoplasmic ATM in neurons modulates synaptic function. Curr Biol 2009, 19(24):2091-2096.
33. Vorhees CV, Williams MT: Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006, 1(2):848-858.
34. Li J, Liu B, Gao X, Ma Z, CaoSong T, Mei YA, Zheng Y: Overexpression of sigma-1 receptor inhibits ADAM10 and ADAM17 mediated shedding in vitro. Protein Cell 2012, 3(2):153-159.
35. Lin JR, Mondal AM, Liu R, Hu J: Minimalist ensemble algorithms for genome-wide protein localization prediction. BMC Bioinformatics 2012, 13:157.
36. Tarbe NG, Rio MC, Hummel S, Weidle UH, Zoller M: Overexpression of the small transmembrane and glycosylated protein SMAGP supports metastasis formation of a rat pancreatic adenocarcinoma line. Int J Cancer 2005, 117(6):913-922.
37. Tarbe NG, Rio MC, Weidle UH: SMAGP, a new small trans-membrane glycoprotein altered in cancer. Oncogene 2004, 23(19):3395-3403.
38. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM: Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39(3):409-421.
39. Yin X, Takei Y, Kido MA, Hirokawa N: Molecular motor KIF17 is fundamental for memory and learning via differential support of synaptic NR2A/2B levels. Neuron 2011, 70(2):310-325.
40. Dziennis S, Alkayed NJ: Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Reviews in the neurosciences 2008, 19(4-5):341-361.
41. Wang XL, Qiao CM, Liu JO, Li CY: Inhibition of the SOCS1-JAK2-STAT3 Signaling Pathway Confers Neuroprotection in Rats with Ischemic Stroke. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2017, 44(1):85-98.
42. Leibinger M, Andreadaki A, Diekmann H, Fischer D: Neuronal STAT3 activation is essential for CNTF- and inflammatory stimulation-induced CNS axon regeneration. Cell death & disease 2013, 4(9):e805.
43. Qin H, Buckley JA, Li X, Liu Y, Fox TH, 3rd, Meares GP, Yu H, Yan Z, Harms AS, Li Y et al: Inhibition of the JAK/STAT Pathway Protects Against alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. The Journal of neuroscience : the official journal of the Society for Neuroscience 2016, 36(18):5144-5159.
44. Tian DS, Peng J, Murugan M, Feng LJ, Liu JL, Eyo UB, Zhou LJ, Mogilevsky R, Wang W, Wu LJ: Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1beta Production after Status Epilepticus. The Journal of neuroscience : the official journal of the Society for Neuroscience 2017, 37(33):7878-7892.
45. Ben Haim L, Ceyzeriat K, Carrillo-de Sauvage MA, Aubry F, Auregan G, Guillermier M, Ruiz M, Petit F, Houitte D, Faivre E et al: The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer's and Huntington's diseases. The Journal of neuroscience : the official journal of the Society for Neuroscience 2015, 35(6):2817-2829.
46. Reichenbach N, Delekate A, Plescher M, Schmitt F, Krauss S, Blank N, Halle A, Petzold GC: Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer's disease model. EMBO Mol Med 2019, 11(2).
47. Wen Y, Yu WH, Maloney B, Bailey J, Ma J, Marie I, Maurin T, Wang L, Figueroa H, Herman M et al: Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron 2008, 57(5):680-690.
48. Butini S, Brogi S, Novellino E, Campiani G, Ghosh AK, Brindisi M, Gemma S: The structural evolution of β-secretase inhibitors: a focus on the development of small-molecule inhibitors. Current topics in medicinal chemistry 2013, 13(15):1787-1807.
49. Sheng M, Sabatini BL, Südhof TC: Synapses and Alzheimer's disease. Cold Spring Harbor perspectives in biology 2012, 4(5).
50. Porter AG, Jänicke RU: Emerging roles of caspase-3 in apoptosis. Cell death and differentiation 1999, 6(2):99-104.
51. Tanabe K, Nakanishi H, Maeda H, Nishioku T, Hashimoto K, Liou SY, Akamine A, Yamamoto K: A predominant apoptotic death pathway of neuronal PC12 cells induced by activated microglia is displaced by a non-apoptotic death pathway following blockage of caspase-3-dependent cascade. The Journal of biological chemistry 1999, 274(22):15725-15731.
52. Nakajima YI, Kuranaga E: Caspase-dependent non-apoptotic processes in development. Cell death and differentiation 2017, 24(8):1422-1430.
53. Hyman BT: Caspase activation without apoptosis: insight into Abeta initiation of neurodegeneration. Nature neuroscience 2011, 14(1):5-6.
54. Sahin GS, Dhar M, Dillon C, Zhu M, Shiina H, Winters BD, Lambert TJ, Impey S, Appleyard SM, Wayman GA: Leptin stimulates synaptogenesis in hippocampal neurons via KLF4 and SOCS3 inhibition of STAT3 signaling. Mol Cell Neurosci 2020, 106:103500.
55. Han JK, Kwon SH, Kim YG, Choi J, Kim JI, Lee YS, Ye SK, Kim SJ: Ablation of STAT3 in Purkinje cells reorganizes cerebellar synaptic plasticity in long-term fear memory network. eLife 2021, 10.
56. Prox J, Rittger A, Saftig P: Physiological functions of the amyloid precursor protein secretases ADAM10, BACE1, and presenilin. Experimental brain research 2012, 217(3-4):331-341.
57. Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, He F, Sun X, Thomas RG et al: A phase 3 trial of semagacestat for treatment of Alzheimer's disease. The New England journal of medicine 2013, 369(4):341-350.
58. Henley DB, Sundell KL, Sethuraman G, Dowsett SA, May PC: Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings. Current medical research and opinion 2014, 30(10):2021-2032.